Larger Men Have Larger Prostates: Detection Bias in Epidemiologic Studies of Obesity and Prostate Cancer Risk
Recommended Citation
Rundle A, Wang Y, Sadasivan S, Chitale DA, Gupta NS, Tang D, and Rybicki BA. Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk. Prostate 2017.
Document Type
Article
Publication Date
6-1-2017
Publication Title
The Prostate
Abstract
BACKGROUND: Obesity is associated with risk of aggressive prostate cancer (PCa), but not with over-all PCa risk. However, obese men have larger prostates which may lower biopsy accuracy and cause a systematic bias toward the null in epidemiologic studies of over-all risk.
METHODS: Within a cohort of 6692 men followed-up after a biopsy or transurethral resection of the prostate (TURP) with benign findings, a nested case-control study was conducted of 495 prostate cancer cases and controls matched on age, race, follow-up duration, biopsy versus TURP, and procedure date. Data on body mass index and prostate volume at the time of the initial procedure were abstracted from medical records.
RESULTS: Prior to consideration of differences in prostate volume, overweight (OR = 1.41; 95%CI 1.01, 1.97), and obese status (OR = 1.59; 95%CI 1.09, 2.33) at the time of the original benign biopsy or TURP were associated with PCa incidence during follow-up. Prostate volume did not significantly moderate the association between body-size and PCa, however it did act as an inverse confounder; adjustment for prostate volume increased the effect size for overweight by 22% (adjusted OR = 1.52; 95%CI 1.08, 2.14) and for obese status by 23% (adjusted OR = 1.77; 95%CI 1.20, 2.62). Larger prostate volume at the time of the original benign biopsy or TURP was inversely associated with PCa incidence during follow-up (OR = 0.92 per 10 cc difference in volume; 95%CI 0.88, 0.97). In analyses that stratified case-control pairs by tumor aggressiveness of the case, prostate volume acted as an inverse confounder in analyses of non-aggressive PCa but not in analyses of aggressive PCa.
CONCLUSIONS: In studies of obesity and PCa, differences in prostate volume cause a bias toward the null, particularly in analyses of non-aggressive PCa. A pervasive underestimation of the association between obesity and overall PCa risk may exist in the literature.
Medical Subject Headings
Bias; Body Mass Index; Body Size; Epidemiologic Studies; Humans; Male; Middle Aged; Obesity; Organ Size; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Risk Factors; Statistics as Topic
PubMed ID
28349547
Volume
77
Issue
9
First Page
949
Last Page
954